| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Bio Research Associates is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Universal Nutrition is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Ann Retirement Center is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Athens Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Athens Regional Medical Center is based in Athens, GA. You can find more information on Athens Regional Medical Center at www.armc.org